Hollow Fiber Filtration Market by Material (Polymeric and Ceramic); Techniques (Microfiltration and Ultrafiltration); Application (Continuous Cell Perfusion, Harvest and Clarification, and Concentration & Diafiltration); End User (Pharmaceutical & Biotechnology Manufacturers, Contract Research & Manufacturing Organizations, R&D Departments, and Other End Users): Global Market Size Estimates and Forecast (2022-2030)

Code: BMIRE00027045 | Pages: 100 | Industry: Medical Device | Date: Oct 2022 | Type: Global

The market crossed the US$ 359.81 million mark in 2022 and is expected to hit US$ 1,040.62 million by 2030, recording a CAGR of 14.2% during the forecast period.

The polymeric material segment holds the largest market share of the hollow fiber filtration market in 2022.

Based on the material, the hollow fiber filtration market is bifurcated into polymeric and ceramic. The polymeric material is further sub-segmented into polysulfide/polyether sulfone (PS/PES), polyvinylidene fluoride (PVDF), and other polymeric materials (cellulose & cellulose acetate, mixed cellulose ester, and polypropylene). The polymeric segment held the largest share in the global polymeric material market in 2022 due to its wide range of applications followed by the hydrophilic nature of polysulfide/polyether sulfone (PS/PES), and low protein-binding properties.

Growth in the biopharmaceutical industry

Biopharmaceutical, as a term, involve the complex process of preparing medicine involves the usage of a living organism or cell.  Penetration of advanced molecules leads to increase usage and development of various biosimilars and biologics. Biopharmaceutical covers most of the large molecule’s preparation which includes vaccine, gene therapy, protein, and various others. Filtration is an important upstream process in biopharmaceutical preparation.

Biopharmaceutical is the most elegant achievement of modern sciences. Currently, the industry generates more than 163 million of revenue each year, and the same accounts for more than 20% of the global pharma market in the year 2022. The industry growing at a growth rate of 10%, double that of the traditional pharma industry. Many pharmaceutical companies are keenly interested in investing in the biopharmaceutical industry due to its wide scope and potency to develop new drugs.  For instance: In August 2020, Sanofi acquired Principia Biopharma. This acquisition advances Sanofi’s ongoing R&D transformation to accelerate the development of the most promising medicines. Thus, the high growth in the biopharmaceutical industry is anticipated to enhance the growth of the hollow fiber filtration market.

Get more information on this report :

Emerging Economies

As biopharmaceuticals are gaining growing shares in the pharmaceutical industry. Growing economies like India, China, and Brazil showed huge growth opportunities for the hollow fiber filtration market. Various companies in China keenly focus on biologics formulation which leads to increased investment from various private companies. For instance, in March 2021, Chime Biologics, a China-based, world-class CDMO company, announced that it has secured a total commitment of US$190 million to accelerate the capacity expansion.

At present, Brazil is in an early stage of the production of biopharmaceuticals. Brazil’s Government provides incentives to various private companies to increase the capacity to produce biopharmaceuticals.  In September 2021, Sinergium Biotech, a private sector biopharmaceutical company, was selected as the center in Argentina. Sinergium will partner with pharmaceutical mAbxience, which belongs to the same group, to develop and manufacture active vaccine ingredients. The two companies have extensive experience in the production and development of vaccines and biotechnological medicines.

Recent strategic developments in the hollow fiber filtration market

The hollow fiber filtration market has undergone several significant developments, and a few of these have been mentioned below:

  • In August 2022, Sartorius acquired Albumedix, the company strengthening its portfolio of innovative advanced therapy solutions. Sartorius will acquire all outstanding shares of Albumedix Ltd. for approximately USD 465 million
  • In February 2022, Sartorius completes the acquisition of Novaseps chromatography division. The portfolio acquired comprises chromatography systems primarily suited for smaller biomolecules, such as oligonucleotides, peptides, and insulin, as well as innovative systems for continuous manufacturing of biologics.
  •  In December 2021, Repligen acquire Bioflex Solution, LLC. The acquisition complements and expands on Repligen’s single-use fluid management products.
  • In September 2021, Repligen Corporation, a life sciences company announced that it has entered into a definitive agreement to acquire privately-held Avitide Inc., for approximately $150 million. Avitide Inc. operates as a biopharmaceutical company. The Company specializes in the discovery and development of custom affinity purification solutions.
  • The hollow fiber filtration market is driven by several players by implementing strategic activities such as investments, new launches, mergers & acquisitions, and partnerships. sahi Kasei Corporation, Repligen Corporation, GE Healthcare, Danaher Corporation, Parker-Hannifin Corporation, Koch Membrane Systems, Inc., Watersep Bioseparation Corporation, Toyobo Co., Ltd., Microdyn-Nadir GmbH, Cantel Medical Corporation are among the prominent players operating in the market.

Target audience for the report:

  • Biopharmaceutical Companies
  • Raw Material Suppliers of Biopharmaceuticals Companies
  • Clinical Research Organization
  • Contract Development and Manufacturing Organization (CDMO)
  • Research institutes, organizations, and consulting companies

Scope of the report:

In this report, the market has been segmented based on:

  • Material:
    • Polymeric
      • PS/PES
      • Polyvinylidene fluoride (PVDF)
      • Other polymeric materials
    • Ceramic
  • Technique:
    • Microfiltration
    • Ultrafiltration
  • Application:
    • Continuous Cell Perfusion
    • Harvest and Clarification
    • Concentration and Diafiltration
  • End User:
    • Pharmaceutical and Biotechnology Manufacturers
    • Contract Research and Manufacturing Organizations
    • R & D Departments
    • Other End Users
  • Region
    • North America
    • Europe
    • Asia Pacific (APAC)
    • South & Central America
    • Middle East & Africa
  • Companies profiled
    • Asahi Kasei Corporation
    • Repligen Corporation
    • GE Healthcare
    • Danaher Corporation
    • Parker-Hannifin Corporation
    • Koch Membrane Systems, Inc.
    • Watersep Bioseparation Corporation
    • Toyobo Co., Ltd.
    • Microdyn-Nadir GmbH
    • Cantel Medical Corporation
    • Others

The List of Companies
- Asahi Kasei Corporation
- Repligen Corporation
- GE Healthcare
- Danaher Corporation
- Parker-Hannifin Corporation
- Koch Membrane Systems, Inc.
- Watersep Bioseparation Corporation
- Toyobo Co., Ltd.
- Microdyn-Nadir GmbH
- Cantel Medical Corporation
- Others

Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement

Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.


Purchase Options
Single User License
$1500
Site License
$2500
Enterprise License
$3500